Petlife Pharmaceuticals Inc Stock Other OTC
Equities
US71639B1052
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
2018 | Petlife Pharmaceuticals, Inc. Announces Management Changes | CI |
Sales 2016 | - | Sales 2017 | - | Capitalization | 8.69M 11.83M |
---|---|---|---|---|---|
Net income 2016 | -3M -4.09M | Net income 2017 | -23M -31.32M | EV / Sales 2016 | - |
Net Debt 2016 | 0.16 0.22 | Net Debt 2017 | 0.66 0.9 | EV / Sales 2017 | - |
P/E ratio 2016 |
-1.86
x | P/E ratio 2017 |
-0.37
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 18-05-29 | |
Vivek Ramana
CTO | Chief Tech/Sci/R&D Officer | 65 | 16-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 18-05-29 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |